About this event

  • Date and time Fri 19 Jun 2020 from 9:00am to 9:00pm
  • Location Royal Society of Medicine
  • Organised by Urology

Please note: This event is postponed. This page will be updated as soon as we have a new date. Apologise for any inconvenience this may have caused. 

This meeting will explore the evidence for intervention with medical hormonal therapy in adolescents with gender dysphoria and the effects of this approach. 

The use of gonadotropin-releasing hormone (GnRH) agonists (more commonly known as hormone or puberty blockers) in transgender adolescents is a contentious topic in regards to the ethics of treating children, evidence-based medicine and long term effects.

The early use of blockers has been suggested as reversible but as treatment of this group increases, issues and challenges in regards to fertility preservation and the effects of future gender reassignment surgery, cognitive and bone health have been highlighted.

This area is very controversial, in society and medical practice, with a judicial review ongoing together with a NICE Review of Evidence. In addition, there is a High Court Case challenging the Gillick Competency in adolescents.

This meeting will provide a balanced and informed debate into the current practice affecting medical practitioners from urology, gynaecology, endocrinology and psychiatry.

Topics include:

  • The evidence for medical intervention in adolescent dysphoria
  • Highlight and understand the controversies in this area
  • The roles of all gender identity specialists in adolescent dysphoria
  • Provide a template for future research and management in this challenging area

*Please note we will need to check all GMC numbers of attendees to this meeting. Ensure you bring this with you, attendance may be denied otherwise.  

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Mr Michael Dineen, President, Section of Urology

The ethics and background to treatment

Introduction

Miss Pippa Sangster, Consultant Urologist and Andrologist, University College London Hospitals NHS Foundation Trust and Mr Roland Morley, Consultant Urologist, Imperial College Healthcare NHS Trust

The ethics behind treating adolescents with blockers

Professor Dominic Wilkinson, Medical Ethics and Neonatology, University of Oxford

What convinces the medical profession that interventions work

Professor Susan Bewley, Consultant Obstetrician and Gynaecologist

Can a child consent to medical treatment - what the law says

Dr Peter Dunne, Senior Lecturer, University of Bristol Law School

Panel discussion
Tea and coffee break

Assessment of childhood dysphoria

Dr Polly Carmichael, Service Director, The Tavistock and Portman NHS Foundation Trust

Co-occurring difficulties

Dr Rebecca McLaren, Consultant Psychiatrist, The Tavistock and Portman NHS Foundation Trust

Assessment of adults for hormonal manipulation and surgery

Professor Christina Richards, Lead Clinical Psychologist, The Tavistock and Portman NHS Foundation Trust

Panel discussion

The neurocognitive implications of early blocker use

Professor Neil Evans, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow

What we know about use of early blockers

Professor Gary Butler, Paediatric Endocrinology, University College London Hospitals NHS Foundation Trust

What we don’t know about the early use of blockers

Dr Peter Hammond. Consultant Endocrinologist, Harrogate and District NHS Foundation Trust 

Panel discussion
Lunch

The long term repercussions of early treatment

Chair: Mr Michael Dineen, President, Section of Urology 

Fertility, the context of regulation

Miss Melanie Davies, Consultant Gynaecologist, Chair of Fertility Preservation UK, British Fertility Society

Fertility preservation natal female

Miss Ephia Yasmin, Consultant Gynaecologist, University College London Hospitals NHS Foundation Trust

Fertility preservation natal male

Miss Pippa Sangster

Adult fertility - can you go back after blockers and hormones

Mr Suks Minhas, Consultant Urologist and Andrologist, Imperial College Healthcare NHS Trust

Panel discussion
Tea and coffee break
Does the use of early blockers affect phalloplasty surgery?

Mr Nim Christopher, Consultant Urologist and Andrologist, University College London Hospitals NHS Foundation Trust

Chairs: Mr Phil Thomas, Consultant Urologist and Genitourinary Reconstructive Surgeon, Nuffield Hospital Brighton and Mr James Bellringer, Consultant Urologist and Genitourinary Reconstructive Surgeon, Parkside Hospital)

Debate: Penile inversion should be the standard for primary surgery

For: Miss Tina Rashid, Consultant Urologist and Genitourinary Reconstructive Surgeon, Imperial College Healthcare NHS Trust

Against: Mr Mark-Bram Bouman, Plastic Reconstructive Gender Surgeon, VU University Medical Center Amsterdam

 

Panel discussion: How we go forward

Chaired by Mr Roland Morley

Professor Gary Butler, Dr Polly Carmichael, Miss Pippa Sangster, Miss Melanie Davies, Professor Susan Bewley

Concluding remarks
Completion of evaluation forms and close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member